Korea Health Industry Development Institute

What Korea Health Industry Development Institute does

KHIDI (Korea Health Industry Development Institute, 한국보건산업진흥원) is a South Korean government-affiliated public institution operating under the Ministry of Health and Welfare, headquartered in Osong Health and Medical Town (Cheongju) with operational offices in Seoul (K-BIC and K-Health MIRAE). Founded in 1998 and structured as a non-commercial state entity, KHIDI functions as the central coordinating body for Korea's biohealth industry — managing national R&D programs, operating startup incubators, promoting Korean medical services abroad, and facilitating global market access for Korean biotech and pharmaceutical companies. It manages flagship national initiatives including the 595.5 billion won Pan-Government Regenerative Medicine Technology Development Project (2021–2030), the K-Health MIRAE mission-driven R&D program modeled after U.S. ARPA-H, K-BIC (Biohealth Innovation Startup Center), and the Medical Korea brand for foreign patient attraction.

KHIDI runs an integrated ecosystem of 15+ specialized platforms covering the pharmaceutical industry (epharmakorea), medical devices (mdtis), senior-friendly industry, health industry statistics (KHISS), medical institution overseas expansion (KOHES), smart hospitals, new technology certification (Health New Technology NET), social economy, research-oriented hospitals, and the COS (Content Open System) — an open-data platform exposing public APIs across matrix services, unified search, health risk assessment, and national nutrition statistics. Its stated technology scope spans bio-convergence platforms for K-Beauty, regenerative medicine, and AI-driven drug development. As a statutory public body, KHIDI generates no commercial revenue; services are funded through government appropriation and delivered without direct cost to beneficiaries.

The institute serves four principal constituencies: Korean pharmaceutical and biotech firms seeking global expansion (e.g., 350+ participants at BIO USA 2026), foreign medical patients (over 2 million in 2025, up from 1.17 million prior year, generating 7.5 trillion won in 2024 spending), biohealth startups and physician-founded founders, and government/regulatory stakeholders. Its go-to-market motion is event- and partnership-driven — hosting Korea Pavilions at BIO USA, co-hosting Novo Nordisk Partnering Day 2026, and operating open-innovation programs with Roche Korea, Basel Area, KIBO, and Cambridge Innovation Center (Boston) to embed Korean firms in global life-sciences hubs. The institute's revenue model is best characterized as professional services funded by government appropriation rather than commercial pricing.

Name

Korea Health Industry Development Institute

Legal name

Korea Health Industry Development Institute (한국보건산업진흥원)

Website

https://khidi.or.kr

Company type

Private

Founded year

1998

Operating status

Operating

Short description

KHIDI is a South Korean government-affiliated public institution under the Ministry of Health and Welfare that promotes the country's biohealth industry through R&D project management, 15+ specialized industry platforms, startup incubation, foreign patient attraction, and international market access programs.

Ownership category

akta.pro rank

Headquarters

HQ city

Seongnam

HQ country

South Korea

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Government-funded public institution services: KHIDI operates as a government-funded public institution providing biohealth industry policy, research, statistics, and support services. The institute does not generate commercial revenue but receives government funding to support the Korean biohealth industry development.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

KHIDI is a South Korean government-affiliated public institution that operates a portfolio of 15+ specialized biohealth industry portals, data platforms, and support programs. It provides policy, market, and technology information for the pharmaceutical, medical device, and senior-friendly industries; runs the K-BIC startup incubation center; promotes Medical Korea for foreign patient attraction; and manages large-scale national R&D initiatives including the Pan-Government Regenerative Medicine Technology Development Project and K-Health MIRAE (ARPA-H-style) program.

Product overview

KHIDI operates as a comprehensive public health industry development organization running 15+ specialized platforms across the bio-health sector. The ecosystem includes industry information portals (pharmaceutical, medical devices, senior-friendly), statistical systems, international expansion support (Medical Korea), R&D management (Health Technology System), startup incubation (Healthcare Industry Innovation Startup Center), smart hospital support, new technology certification (Health New Technology NET), and research hospital networks. The K-Health MIRAE Initiative applies ARPA-H-style mission-driven innovation to healthcare R&D. COS (Content Open System) provides public API access to health data for third-party service development.

Differentiator

Problem solved

Functional benefit

Brands

• K-Health MIRAE (K-헬스미래추진단): A sub-division under KHIDI focused on developing mission-driven, failure-tolerant healthcare R&D innovations, modeled after the U.S. ARPA-H framework.
• K-BIC (보건산업혁신창업센터)
• Medical Korea

Products and services

• Pharmaceutical Industry Information Portal (제약산업정보포털) Integrated platform providing policy, market, and technology information for the entire pharmaceutical industry, supporting domestic pharmaceutical companies' global expansion with latest trends and support program information.
• Medical Device Industry Information (의료기기산업정보) Comprehensive professional information platform providing technology, policy, and market information for the medical device industry, supporting innovation ecosystem and enterprise growth.
• Senior-Friendly Industry (고령친화산업) Support platform providing policy, technology, and market information for senior-friendly industry activation, supporting improved quality of life for elderly through healthcare, nursing, and welfare integration.
• KHISS Health Industry Statistics (보건산업통계) Statistics portal systematically collecting, analyzing, and providing health industry statistical data for policy establishment and industry strategy development.
• Medical Institution Overseas Expansion Information (의료기관 해외진출정보) Information platform supporting domestic medical institutions' overseas expansion, providing business information, country-specific market environments, and support policies.
• Medical Korea Global platform promoting Korea's medical brand 'Medical Korea', providing various content for attracting foreign patients and expanding international medical cooperation.
• Health Medical Technology Comprehensive Information System (htdream) Integrated system providing health medical R&D project announcements, applications, and project management information, supporting researchers and companies' participation in R&D projects.
• K-BIC Healthcare Industry Innovation Startup Center (보건산업혁신창업센터) Full-cycle support platform for bio-health field entrepreneurship and technology commercialization, providing customized support and networks for startup growth stages, with the physical center located in Seoul.
• Smart Hospital Expansion Support Center (스마트병원 확산지원센터) Platform providing policy, case studies, and technology information for digital-based smart hospital expansion, supporting smart hospital model dissemination to innovate medical services and address healthcare gaps.
• Medical Institution Accounting Information Disclosure (의료기관 회계정보 공시) Disclosure system transparently publishing medical institutions' accounting information, supporting citizens' right to know and medical institutions' management transparency.
• Health New Technology NET (보건신기술NET) Health new technology certification platform authenticating and supporting domestic health medical new technologies, helping enterprises and research institutions commercialize excellent technologies and strengthen competitiveness.
• Social Economy Platform (사회적경제플랫폼) Platform supporting growth and cooperation of social economy organizations in the health industry, providing various support information for nurturing prospective social enterprises and expanding distribution channels.
• K-Health MIRAE Initiative (K-헬스미래추진단) Platform promoting challenge-innovation R&D projects to solve healthcare challenges, supporting future medical technology development and national healthcare innovation through mission-driven research, modeled after the U.S. ARPA-H framework.
• Research-Oriented Hospitals (연구중심병원) Platform introducing roles and achievements of research-oriented hospitals where medicine and research are integrated, leading medical technology development through patient-centered treatment and innovation research.
• COS Content Open System (COS 서비스) Open data platform that opens KHIDI's various public information for easy use, enabling third parties to create new services and value through access to health industry data via multiple API services including Matrix Service, Unified Search Service, Health Risk Assessment Service, and National Nutrition Statistics Service.

Quantifiable outcome

• 51 domestic companies participated at Korea Pavilion at BIO USA 2026
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered flagship, core and minor.

• Basel Area Business & InnovationflagshipStrategic or Co-development Partner · 1 May 2026Collaboration with Roche Korea, KHIDI, and KIBO to help Korean biopharma companies expand into global markets through a joint open innovation program launching in May 2026. Roche Korea leads company selection and funding opportunities, KHIDI promotes and operates the program, KIBO evaluates companies and supports financing access, and Basel Area connects companies to its Life Sciences Supercluster and infrastructure.
• Roche KoreaflagshipStrategic or Co-development Partner · 1 May 2026Partnership with KHIDI, KIBO, and Basel Area Business & Innovation for Korean biopharma global expansion. Roche Korea leads company selection and explores funding opportunities within the joint open innovation program.
• Switzerland Innovation Park Basel AreaflagshipImplementation/ SI/ Consulting Partner · 1 May 2026Provides residency support at Switzerland Innovation Park Basel Area as part of the joint open innovation program for Korean biopharma companies expanding into European markets.
• Novo Nordisk Pharma KoreacoreStrategic or Co-development Partner · 22 April 2026Co-hosted Novo Nordisk Partnering Day 2026 with KHIDI and Novo Holdings to support Korean biotech companies in CNS drug development. ImmunoForge won first place with their LMT15 BBB Shuttle Platform at this event.
• Novo HoldingscoreStrategic or Co-development Partner · 22 April 2026Co-hosted Novo Nordisk Partnering Day 2026 with Novo Nordisk Pharma Korea and KHIDI to support Korean biotech companies in CNS drug development and facilitate investment and partnering opportunities.
• UN World Food ProgramcoreStrategic or Co-development Partner · 1 April 2026KHIDI collaborated with Public Procurement Service and UN World Food Program enabling Korean firms to secure initial food supply contracts in the global procurement market.
• Cambridge Innovation Center (CIC)minorImplementation/ SI/ Consulting Partner · 1 April 2025Neurophet was selected for CIC's incubation support program under KHIDI's 2025 Pharmaceutical Industry Global Expansion Consulting Support Program, establishing a Connect & Development office at CIC in Boston.

Scale indicators5 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• Innovate UK: UK's national innovation agency funding business-led R&D and supporting commercialization. Comparable to KHIDI's role as a government-backed platform providing grants, incubation, and global market access support to domestic biohealth startups.
• Enterprise Singapore: Singaporean government agency championing enterprise development and globalization. Comparable to KHIDI's mix of industry policy, overseas expansion support, and platforms like Medical Korea that promote Korean biohealth capabilities internationally.
• Fraunhofer Society: Germany's applied research organization conducting contract R&D and operating industry-facing institutes. Comparable to KHIDI's role bridging national R&D priorities and commercial biohealth industry development across multiple platforms and centers.
• Biomedical Advanced Research and Development Authority (BARDA): U.S. HHS authority that funds and accelerates biomedical R&D for public-health priorities. Comparable to KHIDI's role as a government-affiliated body coordinating large-scale national biohealth R&D investments and industry support.

Direct peers

• Agency for Science, Technology and Research (A*STAR): Singapore's lead public-sector R&D agency supporting biomedical sciences and translational research. Strong regional parallel to KHIDI's mandate to coordinate national biohealth industry development and industry-academia translation.
• Advanced Research Projects Agency for Health (ARPA-H): U.S. federal agency funding high-risk, high-reward health research. Directly comparable to KHIDI's K-Health MIRAE initiative, which is explicitly modeled on the ARPA-H framework for mission-driven, failure-tolerant healthcare R&D.
• Japan Agency for Medical Research and Development (AMED): Japanese government agency funding medical R&D from basic research to clinical translation. Direct regional peer to KHIDI, both serving as national ministries' vehicles for funding and coordinating life-sciences innovation across industry and academia.
• Small Business Corporation (SBC) Korea: Korean government agency supporting startups and SMEs with financing, incubation, and market access. Comparable to KHIDI's K-BIC operations, providing full-cycle support and overseas expansion pathways for biohealth entrepreneurs.
• Korea Trade-Investment Promotion Agency (KOTRA): Korea's government trade and investment promotion agency. Direct domestic peer to KHIDI, both are statutory bodies under Korean ministries running global market entry support programs, partnerships, and event-led GTM for Korean companies.

Regional players

• National Health Service (NHS) England Innovation Service: UK NHS body supporting uptake of healthcare innovation and industry partnerships. Relevant adjacency to KHIDI's Medical Korea platform and K-Health MIRAE mission-driven health innovation agenda, though operating under a public-payer system model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCj8FipI16W8E0ErGxItaQxA
• Facebookfacebook.com/khidi.korea
• LinkedInlinkedin.com/company/khidi-medicaldevice
• Instagraminstagram.com/hello_khidi
• Xx.com/khidi_korea

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Korea Health Industry Development Institute